UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence of psychological distress assessed in emergency departments

Emergency medicine journal : EMJ, 2006-06, Vol.23 (6), p.489-489

2006

Volltextzugriff (PDF)

Access block in NSW hospitals, 1999–2001: does the definition matter?

Medical journal of Australia, 2004-01, Vol.180 (2), p.67-70

2004

Volltextzugriff (PDF)

Utilisation rates of primary care services in an emergency department

Australian family physician, 1994-06, Vol.23 (6), p.1105, 1108

1994

Volltextzugriff (PDF)

Diagnostic Accuracy and Yield of Multidetector CT Angiography in the Evaluation of Spontaneous Intraparenchymal Cerebral Hemorrhage

American journal of neuroradiology : AJNR, 2009-06, Vol.30 (6), p.1213-1221

2009

Volltextzugriff (PDF)

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma

Blood, 2018-07, Vol.132 (1), p.40-48

2018

Volltextzugriff (PDF)

Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-05, Vol.327 (18), p.1771

2022

Volltextzugriff (PDF)

Variations of the antitrypsin property of the serum in patients with gastroduodenal ulcer

Revista espanola de las enfermedades del aparato digestivo, 1978-10, Vol.54 (3), p.253

1978

Volltextzugriff (PDF)

Biological versus mechanical prostheses for aortic valve replacement

The Journal of thoracic and cardiovascular surgery, 2023-02, Vol.165 (2), p.609-617.e7

2023

Volltextzugriff (PDF)

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

The lancet oncology, 2016-02, Vol.17 (2), p.200-211

2016

Volltextzugriff (PDF)

Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2009-09, Vol.27 (26), p.4371-4377

2009

Volltextzugriff (PDF)

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019

Clinical cancer research, 2015-06, Vol.21 (12), p.2771-2779

2015

Volltextzugriff (PDF)

Usefulness of the MPB-INFURG-SEMES model to predict bacteremia in the patient with solid tumor in the Emergency Department

Revista española de quimioterapia, 2024-06, Vol.37 (3), p.257-265

2024

Volltextzugriff (PDF)

Phase II Study of Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Immunochemotherapy Followed by Yttrium-90–Ibritumomab Tiuxetan in Untreated Mantle-Cell Lymphoma: Eastern Cooperative Oncology Group Study E1499

Journal of clinical oncology, 2012-09, Vol.30 (25), p.3119-3126

2012

Volltextzugriff (PDF)

Phase 2, multicenter, open‐label study of tigatuzumab (CS‐1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy‐naive patients with unresectable or metastatic pancreatic cancer

Cancer medicine (Malden, MA), 2013-12, Vol.2 (6), p.925-932

2013

Volltextzugriff (PDF)

Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study

Journal of clinical oncology, 2014-10, Vol.32 (28), p.3137-3143

2014

Volltextzugriff (PDF)

A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia

Blood, 2014-02, Vol.123 (9), p.1302-1308

2014

Volltextzugriff (PDF)

The Prognostic Value of a Validated and Automated Intravascular Ultrasound-Derived Calcium Score

Journal of cardiovascular translational research, 2021-10, Vol.14 (5), p.992-1000

2021

Volltextzugriff (PDF)

Clinical and dermoscopic features of Fibroepithelioma of Pinkus: case series with an emphasis on hypopigmented to pink lines intersecting at acute angles

Archives of Dermatological Research, 2021-10, Vol.313 (8), p.633-640

2021

Volltextzugriff (PDF)

A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies

Clinical cancer research, 2012, Vol.18 (1), p.248-255

2012

Volltextzugriff (PDF)

Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas

Blood, 2018-05, Vol.131 (19), p.2120-2124

2018

Volltextzugriff (PDF)

Procedural Performance of Ultrathin, Biodegradable Polymer-Coated Stents Versus Durable Polymer-Coated Stents Based on Intracoronary Imaging

The Journal of invasive cardiology, 2022-11, Vol.34 (11), p.E811

2022

Volltextzugriff (PDF)

Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system

Journal of antimicrobial chemotherapy, 2009-11, Vol.64 (5), p.1102-1110

2009

Volltextzugriff (PDF)

Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans

PloS one, 2017-09, Vol.12 (9), p.e0183832-e0183832

2017

Volltextzugriff (PDF)

Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study

Anaesthesia, 2021-11, Vol.76 (11), p.1454-1464

2021

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(59)

Sprache

Englisch
(58)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence of psychological distress assessed in emergency departments

Access block in NSW hospitals, 1999–2001: does the definition matter?

Utilisation rates of primary care services in an emergency department

Diagnostic Accuracy and Yield of Multidetector CT Angiography in the Evaluation of Spontaneous Intraparenchymal Cerebral Hemorrhage

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma

Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial

Variations of the antitrypsin property of the serum in patients with gastroduodenal ulcer

Biological versus mechanical prostheses for aortic valve replacement

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019

Usefulness of the MPB-INFURG-SEMES model to predict bacteremia in the patient with solid tumor in the Emergency Department

Phase II Study of Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Immunochemotherapy Followed by Yttrium-90–Ibritumomab Tiuxetan in Untreated Mantle-Cell Lymphoma: Eastern Cooperative Oncology Group Study E1499

Phase 2, multicenter, open‐label study of tigatuzumab (CS‐1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy‐naive patients with unresectable or metastatic pancreatic cancer

Diffuse large B‐cell lymphoma with primary treatment failure: Ultra‐high risk features and benchmarking for experimental therapies

Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study

A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia

The Prognostic Value of a Validated and Automated Intravascular Ultrasound-Derived Calcium Score

Clinical and dermoscopic features of Fibroepithelioma of Pinkus: case series with an emphasis on hypopigmented to pink lines intersecting at acute angles

A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies

Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas

Procedural Performance of Ultrathin, Biodegradable Polymer-Coated Stents Versus Durable Polymer-Coated Stents Based on Intracoronary Imaging

Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system

Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans

Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study

Aktive Filter

Suchergebnisse filtern